Neurol. praxi. 2010;11(1):8-10

Palliative treatment in brain and spinal cord tumours

prof.MUDr.Zdeněk Kadaňka, CSc.
Neurologická klinika, LF MU a FN Brno

First, the author deals with the etymology of the word palliative for a better understanding of its meaning and defines its use in medicine.

Next, he presents a list of the major symptoms accompanying brain tumours that make the lives of patients harder and focuses on

their palliative management. He emphasizes the need for a multidisciplinary approach which should result in a most bearable quality

of life of patients in their last months or years of life, which is not only about relieving the symptoms of disease. A similar approach is

described also for malignant spinal cord tumours including terminal care.

Keywords: palliative care, brain tumours, spinal cord tumours, meningeal carcinomatosis

Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kadaňka Z. Palliative treatment in brain and spinal cord tumours. Neurol. praxi. 2010;11(1):8-10.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Boogerd W, du Bois WF, Teepen LJ, Rosenbrand CJ. Guideline Leptomeningeal metastases of solid tumours. Ned Tijdschr Geneskd 2007; 151: 123-128.
    2. Daszkiewicz P, Barszcz S, Walencik A. Palliative procedures in the management of brain tumours in children. Change of therapeutic strategy over the last 25 years - an institutional experience Department of Neurosurgery of the Children´s Memorial Health Institute in Warsaw. Neurol Neurochir Pol 2007; 41: 321-326. Go to PubMed...
    3. Hasegawa K. Nursing certification system in cancer nursing. Gan To Kagaku Ryoho 2008; 35: 272-277.
    4. Haylock PJ. Living to the end: merging holistic and evidence-based strategies: to meet the needs of people living with advanced cancer. Oncology 2009; 23: 35-40. Go to PubMed...
    5. Chowdhary S, Chamberlain M. Leptomeningeal metastasis: current concept and management guidelines. J Natl Compr Canc Netw 2005; 3: 693-703. Go to original source... Go to PubMed...
    6. Pentheroudakis G, Pavlidis N. Management of leptomeningeal malignancy. Expert Opin Pharmacother 2005; 6: 1115-1125. Go to original source... Go to PubMed...
    7. Strohscheer I, Borasio GD. Carbamazepine - responsive paroxysmal nausea and vomiting in patient with meningeal carcinomatosis. Palliat Med 2006; 20: 549-550. Go to original source... Go to PubMed...
    8. Tang Ji, Back M, Shakespeare T, Lu JJ, Mukherjee R, Wynne C, Liang S. Interpreting the improved outcome of patients with central nervous system metastases managed in clinical trials compared with standard hospital practice. Australa Radiol 2005; 49: 390-395. Go to original source... Go to PubMed...
    9. Tarhini AA, Agarwala SS. Management of brain metastases with melanoma. Curr Opin Oncol 2004; 16: 161-166. Go to original source... Go to PubMed...
    10. Vecht CJ, Hovestadt A, Verbiest HBC, van Vliet JJ, va Putten WL. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumours: A randomized study of doses 4, 8 and 16 mgs per day. Neurology 1994; 44: 675-680. Go to original source... Go to PubMed...
    11. Waki F, Ando M, Takashima A, Yonemori K, Nokihara A, Miyake M, Tateishi U, Tsuta K, Shimada Y, Fujiwara Y. Tamura T. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 2009; 93: 205-212. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.